Home/Filings/4/0001127602-23-014613
4//SEC Filing

Santos Esteban 4

Accession 0001127602-23-014613

CIK 0000318154other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 8:33 PM ET

Size

10.4 KB

Accession

0001127602-23-014613

Insider Transaction Report

Form 4
Period: 2023-05-02
Santos Esteban
EVP, Operations
Transactions
  • Award

    Nqso (Right to Buy)

    2023-05-02+30,10030,100 total
    Exercise: $235.97From: 2025-05-02Exp: 2033-05-02Common Stock (30,100 underlying)
  • Award

    Common Stock

    2023-05-02+3,55964,877 total
  • Tax Payment

    Common Stock

    2023-05-03$235.97/sh716$168,95564,161 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    828.087
Footnotes (5)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 2,268 RSUs which will vest in installments of 1,117 on 5/5/2023 and 1,151 on 5/5/2024; 2,656 RSUs which will vest in installments of 1,308 on 4/30/2024 and 1,348 on 4/30/2025; 3,637 RSUs which will vest in two installments of 1,200 on 5/2/2024 and on 5/2/2025, and one installment of 1,237 on 5/2/2026; and 3,559 RSUs which vest in two installments of 1,174 on 5/2/2025 and 5/2/2026, and 1,211 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 512 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
  • [F5]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001677950

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 8:33 PM ET
Size
10.4 KB